Fairvalue-Calculator Fairvalue-Calculator
EN DE

Kukje Pharma Co (002720) Fair Value & Analysis

Healthcare · KR · Market cap 74.5B KRW

Price3,275 KRW
Fair Value3,916 KRW
Upside+19.6%
Quality95/100
Evidence: High Range 3,511 KRW – 5,668 KRW

Fair value as of: Jun 25, 2026

Analysis

Kukje Pharma Co (002720) currently trades at 3,275 KRW, while our model-based Fair Value estimate is 3,916 KRW — implying the stock looks roughly 19.6% undervalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.

About the company

Kukje Pharma Co., Ltd. engages in manufacturing, importing, exporting, selling, and distributing pharmaceutical products. The company offers pharmaceutical products, including ETC and OTC products, raw materials, intermediates, and side chain products, as well as cosmetics and health care products. Its products include cephalosporins, quinolones, tetracycline, aminoglycosides, macrolides, other antibiotics, ophthalmic, antifungal and antiviral agents, ophthalmic agents, adrenal corticosteroids, CNS and osteoporotic agents, antihistamines, NSAIDS and other analgesics, gastrointestinal and cardiovascular agents, antidiabetics, genitourinary and respiratory agents, other ETC products, and other products. Kukje Pharma Co., Ltd. was founded in 1959 and is headquartered in Seongnam-si, South Korea.

Open the full interactive analysis →

Similar stocks

Takeda Pharmaceutical Company (TAKP34) +1949% Jiangsu Hengrui Pharmaceuticals Co (600276) -46% Sun Pharmaceutical Industries Limited (SUNPHARMA) -44% Zoetis Inc (Z1TS34) -74% Hansoh Pharmaceutical Group (3692) -47% Divi's Laboratories Limited (DIVISLAB) -70%

Frequently asked questions

Is Kukje Pharma Co (002720) undervalued?
As of Jun 25, 2026, our model estimates a fair value of 3,916 KRW versus a price of 3,275 KRW — about +20% (undervalued). Model-based estimate, not financial advice.
What is the fair value of 002720?
Our 21-model fair value for Kukje Pharma Co is 3,916 KRW (as of Jun 25, 2026), built from audited fundamentals. The current price is 3,275 KRW.
What is the quality score of 002720?
Kukje Pharma Co has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.